Position
Engineers Gate Manager LP in Theravance Biopharma, Inc.
Back to the book · All holders of TBPH
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$101.7K$18.71 → $16.23
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 41K | $767.3K | — | — | — | 0.0% |
| Q1 2026 | 113.2K | $1.84M | $16.23 | −$101.7K | $1.17M | 0.0% |